 | Novo Nordisk: The tide has begun to turn |
07 May 2026 at 12:10 am AEST
|
| Novo Nordisk: Slipping expectations frustrate investors again and again |
12 February 2026 at 05:08 pm AEDT
|
| Novo Nordisk: What is Novo really up against? |
06 February 2026 at 04:58 am AEDT
|
 | Novo Nordisk exposed to a price war over obesity treatments |
05 February 2026 at 06:38 am AEDT
|
| Novo Nordisk: Disappointing the markets is becoming a habit |
05 February 2026 at 12:15 am AEDT
|
 | Novo Nordisk plunges as its 2026 outlook rattles investors |
04 February 2026 at 10:10 pm AEDT
|
| Novo Nordisk steady amid Lilly Retatrutide risks |
13 December 2025 at 03:14 am AEDT
|
 | No plane sailing for Novo Nordisk |
26 November 2025 at 12:20 am AEDT
|
 | Novo Nordisk valuation hit by obesity fears |
25 November 2025 at 08:42 pm AEDT
|
| Novo Nordisk faces US drug price cuts but gains wider obesity coverage |
11 November 2025 at 12:52 am AEDT
|
| Novo Nordisk faces earnings miss and guidance cut amid obesity drug Competition |
06 November 2025 at 02:16 am AEDT
|
| Novo Nordisk: Exhibiting aggression, Novo gatecrashes Pfizer-Metsera's party |
01 October 2025 at 01:18 am AEDT
|
 | All hands on deck at Novo Nordisk! |
10 September 2025 at 08:04 pm AEST
|
 | Novo Nordisk: Wegovy - beyond diabetes and obesity |
19 August 2025 at 06:17 pm AEST
|
| Novo Nordisk falters once again |
29 July 2025 at 11:39 pm AEST
|
 | How did Novo Nordisk lose the US market? |
02 July 2025 at 08:11 pm AEST
|
 | The Parvus fund enters Novo Nordisk's capital |
10 June 2025 at 10:06 pm AEST
|
 | Wegovy on the rise amongst American teens; between effectiveness and reluctance |
04 June 2025 at 07:01 pm AEST
|
 | Novo Nordisk CEO ousted as battle against obesity intensifies |
16 May 2025 at 11:40 pm AEST
|
 | MarketScreener roundup: abysmal trade deficit and massive share buybacks in the US; Novo Nordisk's valuation on a diet |
07 May 2025 at 08:06 pm AEST
|
 | Novo Nordisk is weak, but that's enough |
07 May 2025 at 06:27 pm AEST
|
 | Novo Nordisk: Penalized by Eli Lilly's success |
22 April 2025 at 10:06 pm AEST
|
 | Novo Nordisk under threat from first anti-obesity generics |
11 March 2025 at 01:37 am AEDT
|
 | Cagrisema sends Novo Nordisk to the mat |
20 December 2024 at 10:20 pm AEDT
|
 | Novo Nordisk A/S: Volatility continues unabated |
08 November 2024 at 04:28 am AEDT
|
